Melanoma diagnosed 27 years after a benoxaprofen-induced photosensitivity reaction

[摘要] The propionic acid derivative Benoxaprofen was introduced for the treatment of rheumatic disorders in 1980. Its product license was then withdrawn 2 years later due to concerns over serious dermatologic, hepatic and renal side effects. Photosensitivity was the most common side effect with reported incidence of up to 50%.

[学科分类] 皮肤病学

[关键词] benoxaprofen;malignant melanoma;photosensitivity;Opren®